The debt of Vaxcyte, Inc. over the past 8 years
Chart Vaxcyte, Inc.: liquid cash, total debt, net cash, fiscal 2018–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Vaxcyte, Inc. had liquid cash of $1.56B and total debt of $0: net cash of $1.56B. It had more liquid cash than debt at all 7 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $1.56B* | $0 | $1.56B |
| 2024ended Dec 31, 2024 | $1.75B* | $0 | $1.75B |
| 2023ended Dec 31, 2023 | $1.08B* | $0 | $1.08B |
| 2022ended Dec 31, 2022 | $931.38M* | $0 | $931.38M |
| 2021ended Dec 31, 2021 | $245.97M* | $0 | $245.97M |
| 2020ended Dec 31, 2020 | $386.2M | $0 | $386.2M |
| 2019ended Dec 31, 2019 | $58.98M | $0 | $58.98M |
| 2018ended Dec 31, 2018 | — | — | — |
Fiscal years as Vaxcyte, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Vaxcyte, Inc.
- The profitability of Vaxcyte, Inc.
- The cash flow of Vaxcyte, Inc.
- All of Vaxcyte, Inc.'s financials, charted
Companies of a similar size
- TWSTTwist Bioscience Corporation
- ZETAZeta Global Holdings Corp.
- HQYHEALTHEQUITY, INC.
- REXRRexford Industrial Realty, Inc.
- FLSFLOWSERVE CORP
Not investment advice. This page shows what Vaxcyte, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.